Search

Rodney Barnett White

Examiner (ID: 4089, Phone: (571)272-6863 , Office: P/3636 )

Most Active Art Unit
3636
Art Unit(s)
3636, 3507, 3624
Total Applications
3742
Issued Applications
3058
Pending Applications
192
Abandoned Applications
490

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14609563 [patent_doc_number] => 10357459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-23 [patent_title] => Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents [patent_app_type] => utility [patent_app_number] => 15/629636 [patent_app_country] => US [patent_app_date] => 2017-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 8570 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15629636 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/629636
Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents Jun 20, 2017 Issued
Array ( [id] => 14169143 [patent_doc_number] => 10258557 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-16 [patent_title] => Peptide for stimulating melanogenesis [patent_app_type] => utility [patent_app_number] => 15/626891 [patent_app_country] => US [patent_app_date] => 2017-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 2287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15626891 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/626891
Peptide for stimulating melanogenesis Jun 18, 2017 Issued
Array ( [id] => 14088061 [patent_doc_number] => 10239924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-03-26 [patent_title] => Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells [patent_app_type] => utility [patent_app_number] => 15/624906 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 4084 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15624906 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/624906
Peptide having eight amino acid sequences derived from cage and retaining anticancer activity and activity to promote anticancer drug sensitivity of anticancer drug-resistant cancer cells Jun 15, 2017 Issued
Array ( [id] => 14652687 [patent_doc_number] => 20190233472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => NOVEL TRIPEPTIDE [patent_app_type] => utility [patent_app_number] => 16/309641 [patent_app_country] => US [patent_app_date] => 2017-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3731 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16309641 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/309641
Tripeptides having angiotensin converting enzyme inhibitory activity and uses thereof Jun 15, 2017 Issued
Array ( [id] => 15267423 [patent_doc_number] => 20190382445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-12-19 [patent_title] => PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME [patent_app_type] => utility [patent_app_number] => 16/308410 [patent_app_country] => US [patent_app_date] => 2017-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4139 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16308410 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/308410
PEPTIDE HAVING MELANOGENESIS-INHIBITING ACTIVITY AND COMPOSITION COMPRISING SAME Jun 8, 2017 Abandoned
Array ( [id] => 11977587 [patent_doc_number] => 20170281742 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'H3.3 CTL Peptides and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 15/613837 [patent_app_country] => US [patent_app_date] => 2017-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 18660 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15613837 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/613837
H3.3 CTL peptides and uses thereof Jun 4, 2017 Issued
Array ( [id] => 12092536 [patent_doc_number] => 20170349629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-07 [patent_title] => 'Angiotensin-1-Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 15/612763 [patent_app_country] => US [patent_app_date] => 2017-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10510 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15612763 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/612763
Angiotensin-1-receptor antagonists Jun 1, 2017 Issued
Array ( [id] => 11963569 [patent_doc_number] => 20170267722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-21 [patent_title] => 'INHIBITORY PEPTIDES OF VIRAL INFECTION' [patent_app_type] => utility [patent_app_number] => 15/605877 [patent_app_country] => US [patent_app_date] => 2017-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19647 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15605877 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/605877
Inhibitory peptides of viral infection May 24, 2017 Issued
Array ( [id] => 14497927 [patent_doc_number] => 20190192618 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-06-27 [patent_title] => SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE [patent_app_type] => utility [patent_app_number] => 16/301355 [patent_app_country] => US [patent_app_date] => 2017-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3910 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301355 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/301355
SPR741 HUMAN PHARMACOKINETICS AND EFFICACIOUS DOSE May 14, 2017 Abandoned
Array ( [id] => 11992465 [patent_doc_number] => 20170296620 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'BIS-SULFHYDRYL MACROCYCLIZATION SYSTEMS' [patent_app_type] => utility [patent_app_number] => 15/592517 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 18962 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15592517 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/592517
Bis-sulfhydryl macrocyclization systems May 10, 2017 Issued
Array ( [id] => 16304158 [patent_doc_number] => 10772929 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-09-15 [patent_title] => Use of peptide compounds in treating acute pancreatitis [patent_app_type] => utility [patent_app_number] => 16/094881 [patent_app_country] => US [patent_app_date] => 2017-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 13 [patent_no_of_words] => 6349 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16094881 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/094881
Use of peptide compounds in treating acute pancreatitis May 10, 2017 Issued
Array ( [id] => 16498886 [patent_doc_number] => 10864253 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-15 [patent_title] => Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage [patent_app_type] => utility [patent_app_number] => 16/096247 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 29982 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16096247 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/096247
Tissue protective peptides for preventing and treating diseases and disorders associated with tissue damage Apr 27, 2017 Issued
Array ( [id] => 14581289 [patent_doc_number] => 20190218253 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-18 [patent_title] => Therapeutic SALL4 Peptide [patent_app_type] => utility [patent_app_number] => 16/095603 [patent_app_country] => US [patent_app_date] => 2017-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14566 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16095603 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/095603
Therapeutic spalt-like transcription factor 4 (SALL4) peptide Apr 27, 2017 Issued
Array ( [id] => 16105391 [patent_doc_number] => 10695279 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-30 [patent_title] => Peptide having skin-whitening activity and use thereof [patent_app_type] => utility [patent_app_number] => 15/554067 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 5747 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554067 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/554067
Peptide having skin-whitening activity and use thereof Apr 26, 2017 Issued
Array ( [id] => 11866159 [patent_doc_number] => 20170233445 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-17 [patent_title] => 'ANTI-MICROBIAL PEPTIDE AND METHOD FOR TREATING MICROBIAL INFECTION' [patent_app_type] => utility [patent_app_number] => 15/498482 [patent_app_country] => US [patent_app_date] => 2017-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 8416 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15498482 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/498482
Anti-microbial peptide and method for treating microbial infection Apr 26, 2017 Issued
Array ( [id] => 11979314 [patent_doc_number] => 20170283468 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-05 [patent_title] => 'PEPTIDES FOR DIAGNOSIS AND TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 15/497851 [patent_app_country] => US [patent_app_date] => 2017-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 10346 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15497851 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/497851
Peptides for diagnosis and treatment of cancer Apr 25, 2017 Issued
Array ( [id] => 14868009 [patent_doc_number] => 20190284246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-19 [patent_title] => PEPTIDE INHIBITING COLONIZATION BY PATHOGENIC BACTERIA, AND COLONIZATION INHIBITOR INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 16/097219 [patent_app_country] => US [patent_app_date] => 2017-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11648 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16097219 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/097219
Peptide inhibiting colonization by pathogenic bacteria, and colonization inhibitor including same Apr 24, 2017 Issued
Array ( [id] => 11852044 [patent_doc_number] => 20170226537 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-08-10 [patent_title] => 'ALCOHOL PRODUCT PROCESSES' [patent_app_type] => utility [patent_app_number] => 15/495027 [patent_app_country] => US [patent_app_date] => 2017-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13720 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15495027 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/495027
ALCOHOL PRODUCT PROCESSES Apr 23, 2017 Abandoned
Array ( [id] => 11993944 [patent_doc_number] => 20170298099 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES' [patent_app_type] => utility [patent_app_number] => 15/493301 [patent_app_country] => US [patent_app_date] => 2017-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 36765 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15493301 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/493301
BIOLOGICALLY ACTIVE PEPTIDOMIMETIC MACROCYCLES Apr 20, 2017 Abandoned
Array ( [id] => 11994170 [patent_doc_number] => 20170298326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-19 [patent_title] => 'VARIANT FORMS OF URATE OXIDASE AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 15/490736 [patent_app_country] => US [patent_app_date] => 2017-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14849 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15490736 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/490736
VARIANT FORMS OF URATE OXIDASE AND USE THEREOF Apr 17, 2017 Abandoned
Menu